TriRx To Buy Elanco Animal Health Facilities In Shawnee, Kansas And Speke, U.K.

(RTTNews) - TriRx Pharmaceutical Services Inc. said that it agreed to acquire two facilities from Elanco Animal Health Inc. (ELAN).

The sites are located in Shawnee, Kansas and Speke, United Kingdom, and will expand the manufacturing footprint of TriRx, adding to its existing pharmaceutical facilities in Huntsville, Alabama, and Segré, France.

The sale of the Shawnee and Speke sites includes the physical assets at both locations and the transfer of about 600 employees. The two companies have also entered into long-term supply agreements for both facilities to continue to manufacture existing Elanco products.

The sale of the Shawnee facility is expected to close in the second half of 2021, while the Speke facility sale is expected to close by early 2022.